Science News

Discover the news and inspiring materials from the world of biotechnology.

The use of GLP-1 analogs is growing rapidly in obese and overweight patients who need to control body weight.

Popular obesity drug cuts the risk of heart attacks and strokes

Semaglutide (Ozempic) has been found to reduce the risk of cardiovascular events in obese people.

Learn more

FDA approves first ustekinumab biosimilar

FDA approves first ustekinumab biosimilar Ustekinumab (Stelara®), a blockbuster monoclonal antibody originally developed by Janssen Pharmaceuticals, has just got a biosimilar counterpart. The new biosimilar, Wezlana®, manufactured by Amgen, received FDA approval in all indications of the originator, which include plaque psoriasis, psoriatic arthritis, Crohn’s disease and ulcerative colitis. The FDA also granted it an […]

Learn more

Another win for antibody-drug conjugates in breast cancer

Sacituzumab govitecan, an antibody-drug conjugate targeting Trop-2 antigen, was reported to increase survival in HR-positive, EGFR2-negative breast cancer.

Learn more

Updated Novavax’s COVID vaccine effectively neutralizes…

Novavax’s vaccine for 2023-24 season induced neutralizing responses against newly emerging subvariants EG.5.1 and XBB.1.16.6. in in vivo models.

Learn more

Market welcomes the arrival of new RSV vaccines

The FDA has approved novel vaccines preventing the grave complications of RSV infection.

Learn more
Mabion purchase Cytiva Xcellerex™ XDR bioreactors with conventional mixing technology

Mabion purchase of new Cytiva Xcellerex™ XDR bioreactors

Mabion signs contract to purchase new bioreactors diversifies technology and opens to new customers.

Learn more